Contact person
Ole Henrik Brekke
Address
Gaustadalleen 21. 0349, Oslo, Norway
Employees
10
Established
2009
Nextera is a drug and target discovery company offering a unique and novel approach for improved therapeutic intervention in the major disease areas autoimmunity, chronic inflammatory disorders and cancer. Our approach is to modulate the disease at the core of the escalating immune cascade translating to disease-specific treatment without compromising systemic immunity.